Longitude Capital (investor - Venture Capital)

See something wrong or missing? Let us know
Offices:California

Longitude Capital is a California-based venture capital firm that invests in biotechnology and medical technology companies.

Average round investment:85.73M USD
Average number per year:1.5
Distribution: 2026 (1)2024 (2)2022 (2)2020 (1)
Mostly invests in: Switzerland Switzerland (4) Health services (6)
See the entire list

Showing 3 of 6 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Longitude Capital

Name Criteria
Ireland KCK Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Ireland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
France Renault Group
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Hardware, Wearable
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Axial VC
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Elevage Medical Technologies
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware, Wearable
  • Similar business models: B2B
  • Common investees countries: Ireland
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Arm Holdings
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Israel aMoon
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, France
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Medicxi
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, Ireland
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
South Korea Korea Investment Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Switzerland Korify Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
France Lauxera Capital Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top